ArticleNucleic acids research2026
The HigB-like SehA toxin promotes non-replicating Salmonella inside macrophages by inhibiting ribonuclease III-dependent rRNA maturation.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Many bacteria are often resistant to antibiotic treatment because they can slow down their growth rate, thereby attenuating the drug's effectiveness. A similar growth slowdown is observed in pathogens that persist inside their hosts. The bacterial toxin-antitoxin systems serve as tunable phenotypic switches by slowing down growth through the expression of a toxin component, though its biological target has been largely unknown. Here, we investigate the biological target of SehA, a HigB-like type II toxin from the intracellular pathogen Salmonella Typhimurium. Contrary to its predicted endoribonuclease function, it does not exhibit endoribonuclease activity. Instead, it inhibits ribonuclease III that mediates the initial cleavage for ribosomal RNA processing. The toxin binds to the dsRNA-binding domain of RNase III, thereby decreasing ribosome assembly and bacterial growth. Given that the SehA toxin induces persister formation within macrophages in an RNase III-dependent manner, inhibition of RNase III represents a newly identified biological target for pathogen persistence within hosts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.